SCHEMBL28797803

SCHEMBL28797803

C[Si](C)(C)C#Cc1cnc(-c2ccccc2)nc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 2/20 0.43
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
KMT2A Q03164 2/20 0.39
ADORA1 P30542 4/20 0.38
ADORA2A P29274 3/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TKT P29401 1/20 0.38
POLB P06746 2/20 0.37
ADORA3 P0DMS8 2/20 0.37
ADORA2B P29275 1/20 0.37
DHFR P00374 1/20 0.37
NOTUM Q6P988 1/20 0.37
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2071638 0.84 NPC1 (0.45) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL11260015 0.78 ADORA2A (0.57) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL2068990 0.78 NPC1 (0.43) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL5925906 0.74 LMNA (0.40) TKTDHFRLMNAKDM4E
SCHEMBL27871327 0.72 NPC1 (0.47) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL482479 0.71 NPC1 (0.50) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL31506189 0.70 ITK (0.40) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL26985823 0.70 ITK (0.40) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL27735106 0.70 FGFR1 (0.49) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
Hydrochloric Acid SCHEMBL4144361 0.70 NPC1 (0.48) NPC1RAB9ASMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102656164-A Pyrimidine compounds as tuberculosis inhibitors VERTEX PHARMA 2012-09-05 CN disclosed